INS and fatty liver disease: Insulin resistance (IR) plays a pivotal role in hepatic steatosis development by rendering AT resistant to insulin’s antilipolytic effects, leading to increased release of free fatty acids (FFAs) that accumulate as TGs in the liver [16].